Načítá se...
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis
OBJECTIVE: Deferiprone is an iron chelator that has recently been used to treat patients with infratentorial superficial siderosis (iSS). It is considered to have a generally favourable safety profile but concerns have been raised due to the risk of agranulocytosis. We aimed to evaluate the safety a...
Uloženo v:
| Vydáno v: | J Neurol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6954889/ https://ncbi.nlm.nih.gov/pubmed/31620867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-019-09577-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|